Skip to content
★ Sign in to follow
MS

Michael S. Poirier

Executive
Chairman & CEO
Qualigen Therapeutics, Inc.
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€33k
▼ Sales (0 ops.)
—

Latest filing published 22 Jun 2022 for Qualigen Therapeutics, Inc., €16k.

Filing timeline

BuySale
Michael S. Poirier

Insider track record

Disclosed buys
2
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Michael S. Poirier: trading record in brief

All filings by Michael S. Poirier on record concern FF EAI Robotics Ecosystem Inc., in the capacity of chief executive. We count 3 filings; the first trade dates from 22 May 2020 and the latest from 22 June 2022.

Purchases make up the whole of the open-market record (2 purchases, €33k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2022 to date brings 1 purchase and no sales.

The record was last updated on 22 June 2022 with an open-market purchase (€16k) in FF EAI Robotics Ecosystem Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael S. Poirier

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

1 of 1 declaration